The Hope Foundation for Cancer Research: Supporting SWOG Cancer Research Network
The Hope Foundation for Cancer Research is the public charity supporting SWOG Cancer Research Network.
Related Articles
Validate User
We are sorry, but we are experiencing unusual traffic at this time. Please help us confirm that you are not a robot and we will…
Trans Dudes with Lady Cancer
A documentary film where the title says it all, except… They are housemates and were diagnosed in the same month.
A Sneak Peek at Spring in Seattle | SWOG
As with last fall’s group meeting, you can install our meeting app on your smart phone (Android or Apple), or you can simply use the online version in…
Advances and challenges in cancer immunoprevention and immune interception
Invasive cancers typically evade immune surveillance through profound local and systemic immunosuppression, preventing their elimination or control. Targeting immune interventions to prevent or intercept premalignant…
Pilot Studies: When Efficacy Is Not the Primary Question | SWOG
Pilot studies can answer questions about whether a given trial design is feasible within the bounds of the National Clinical Trials Network and/or the NCI…
Better Integration of Community Oncologists into All We Do | SWOG
In recent years, community sites – specifically within the NCI Community Oncology Research Program (NCORP) – have accounted for about one-half of all SWOG-credited trial…
S2210 | SWOG
1. Disease Related Criteria Participant must have histologic diagnosis of prostate adenocarcinoma.Participant must have high or very high-risk disease defined by at least one of…
Carboplatin Chemotherapy Before Surgery For People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation | SWOG
Clinical Trial Summary (S2210) What is the purpose of this clinical trial? This trial tests treatment for prostate cancer that is at high risk of…
Hope … Springs Eternal | SWOG
Continuing that noble tradition, the newest Hope program is the Frank and Linda Meyskens Annual Endowed Lectureship on Advances in Cancer Prevention, which will sponsor…
Targeting ATR in patients with cancer
Nature Reviews Clinical Oncology – Ataxia telangiectasia and Rad3-related protein serine/threonine kinase (ATR) is a mediator of the cellular replication stress response that, upon activation,…